Literature DB >> 24305849

Essential health benefits and the Affordable Care Act: law and process.

Nicholas Bagley1, Helen Levy.   

Abstract

Starting in 2014, the Affordable Care Act (ACA) will require private insurance plans sold in the individual and small-group markets to cover a roster of "essential health benefits." Precisely which benefits should count as essential, however, was left to the discretion of the Department of Health and Human Services (HHS). The matter was both important and controversial. Nonetheless, HHS announced its policy by posting on the Internet a thirteen-page bulletin stating that it would allow each state to define essential benefits for itself. On both substance and procedure, the move was surprising. The state-by-state approach departed from the uniform, federal standard that the ACA appears to anticipate and that informed observers expected HHS to adopt. And announcing the policy through an Internet bulletin appeared to allow HHS to sidestep traditional administrative procedures, including notice and comment, immediate review in the courts, and White House oversight. This article explores two questions. First, is the state-by-state approach a lawful exercise of HHS's authority? Second, did HHS in fact evade the procedural obligations that are meant to shape the exercise of its discretion?

Entities:  

Mesh:

Year:  2013        PMID: 24305849      PMCID: PMC4116669          DOI: 10.1215/03616878-2416325

Source DB:  PubMed          Journal:  J Health Polit Policy Law        ISSN: 0361-6878            Impact factor:   2.265


  3 in total

1.  Regulatory beneficiaries and informal agency policymaking.

Authors:  Nina A Mendelson
Journal:  Cornell Law Rev       Date:  2007-03

Review 2.  Overview of meta-analyses on early intensive behavioral intervention for young children with autism spectrum disorders.

Authors:  Brian Reichow
Journal:  J Autism Dev Disord       Date:  2012-04

3.  Patient Protection and Affordable Care Act; standards related to essential health benefits, actuarial value and accreditation. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2013-02-25
  3 in total
  7 in total

1.  Repealing the Affordable Care Act Essential Health Benefits: Threats and Obstacles.

Authors:  Charley E Willison; Phillip M Singer
Journal:  Am J Public Health       Date:  2017-08       Impact factor: 9.308

Review 2.  Will the Affordable Care Act (ACA) Improve Racial/Ethnic Disparity of Eye Examination Among US Working-Age Population with Diabetes?

Authors:  Qian Shi; Vivian Fonseca; Marie Krousel-Wood; Yingnan Zhao; Frank P Nellans; Qingyang Luo; Lizheng Shi
Journal:  Curr Diab Rep       Date:  2016-07       Impact factor: 4.810

Review 3.  Improving Behavioral Health Services in the Time of COVID-19 and Racial Inequities.

Authors:  Ruth S Shim; Matthew Tierney; Martin H Rosenzweig; Howard H Goldman
Journal:  NAM Perspect       Date:  2021-11-01

4.  The Affordable Care Act and suicide incidence among adults with cancer.

Authors:  Justin M Barnes; Evan M Graboyes; Eric Adjei Boakye; Erin E Kent; Jeffrey F Scherrer; Eliza M Park; Donald L Rosenstein; Yvonne M Mowery; Junzo P Chino; David M Brizel; Nosayaba Osazuwa-Peters
Journal:  J Cancer Surviv       Date:  2022-04-04       Impact factor: 4.442

5.  Association of Medicaid Expansion With Insurance Coverage Among Children With Cancer.

Authors:  Justin M Barnes; Abigail R Barker; Allison A King; Kimberly J Johnson
Journal:  JAMA Pediatr       Date:  2020-06-01       Impact factor: 16.193

6.  Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.

Authors:  Mary Catherine Cambou; Timothy P Copeland; Karin Nielsen-Saines; James Macinko
Journal:  Vaccine       Date:  2021-03-18       Impact factor: 3.641

7.  Autism spectrum disorder, politics, and the generosity of insurance mandates in the United States.

Authors:  Timothy Callaghan; Steven Sylvester
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.